BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 29309493)

  • 1. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.
    Santos-Santos MA; Rabinovici GD; Iaccarino L; Ayakta N; Tammewar G; Lobach I; Henry ML; Hubbard I; Mandelli ML; Spinelli E; Miller ZA; Pressman PS; O'Neil JP; Ghosh P; Lazaris A; Meyer M; Watson C; Yoon SJ; Rosen HJ; Grinberg L; Seeley WW; Miller BL; Jagust WJ; Gorno-Tempini ML
    JAMA Neurol; 2018 Mar; 75(3):342-352. PubMed ID: 29309493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid PET Positivity in Different Primary Progressive Aphasia Phenotypes.
    Beaufils E; Vercouillie J; Vierron E; Cottier JP; Camus V; Mondon K; Guilloteau D; Hommet C; Ribeiro MJ
    Clin Nucl Med; 2018 Apr; 43(4):e103-e108. PubMed ID: 29504965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-phase
    Kuo HC; Hsiao IT; Hsieh CJ; Huang CY; Huang KL; Wai YY; Chuang WL; Kung MP; Chu YC; Yen TC; Lin KJ; Huang CC
    J Formos Med Assoc; 2017 Dec; 116(12):964-972. PubMed ID: 28434708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia.
    Schaeverbeke J; Gabel S; Meersmans K; Bruffaerts R; Liuzzi AG; Evenepoel C; Dries E; Van Bouwel K; Sieben A; Pijnenburg Y; Peeters R; Bormans G; Van Laere K; Koole M; Dupont P; Vandenberghe R
    Alzheimers Res Ther; 2018 Jul; 10(1):68. PubMed ID: 30021613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid pet in primary progressive aphasia: case series and systematic review of the literature.
    Villarejo-Galende A; Llamas-Velasco S; Gómez-Grande A; Puertas-Martín V; Contador I; Sarandeses P; González-Sánchez M; Trincado R; Pilkington P; Ruiz-Solis S; Pérez-Martínez DA; Herrero-San Martín A
    J Neurol; 2017 Jan; 264(1):121-130. PubMed ID: 27815682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.
    Ramanan S; Flanagan E; Leyton CE; Villemagne VL; Rowe CC; Hodges JR; Hornberger M
    J Alzheimers Dis; 2016; 51(2):367-76. PubMed ID: 26890745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Cerebrospinal Fluid Biomarkers and (18)F-florbetapir PET Imaging in the Diagnosis of Primary Progressive Aphasia: A Retrospective Analysis.
    Perini G; Cotta Ramusino M; Sinforiani E; Franciotta D; Trifirò G; Ceroni M; Costa A
    Alzheimer Dis Assoc Disord; 2019; 33(3):282-284. PubMed ID: 30640253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phonologic errors as a clinical marker of the logopenic variant of PPA.
    Leyton CE; Ballard KJ; Piguet O; Hodges JR
    Neurology; 2014 May; 82(18):1620-7. PubMed ID: 24706011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging.
    Leyton CE; Villemagne VL; Savage S; Pike KE; Ballard KJ; Piguet O; Burrell JR; Rowe CC; Hodges JR
    Brain; 2011 Oct; 134(Pt 10):3030-43. PubMed ID: 21908392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
    Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
    Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias.
    Mendes A; Bertrand A; Lamari F; Colliot O; Routier A; Godefroy O; Etcharry-Bouyx F; Moreaud O; Pasquier F; Couratier P; Bennys K; Vercelletto M; Martinaud O; Laurent B; Pariente J; Puel M; Epelbaum S; Belliard S; Kaaouana T; Fillon L; Chupin M; Dubois B; Teichmann M;
    Neurology; 2018 Mar; 90(12):e1057-e1065. PubMed ID: 29444966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification and pathology of primary progressive aphasia.
    Harris JM; Gall C; Thompson JC; Richardson AM; Neary D; du Plessis D; Pal P; Mann DM; Snowden JS; Jones M
    Neurology; 2013 Nov; 81(21):1832-9. PubMed ID: 24142474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
    Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
    J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting primary progressive aphasias with support vector machine approaches in structural MRI data.
    Bisenius S; Mueller K; Diehl-Schmid J; Fassbender K; Grimmer T; Jessen F; Kassubek J; Kornhuber J; Landwehrmeyer B; Ludolph A; Schneider A; Anderl-Straub S; Stuke K; Danek A; Otto M; Schroeter ML;
    Neuroimage Clin; 2017; 14():334-343. PubMed ID: 28229040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apraxia of speech and phonological errors in the diagnosis of nonfluent/agrammatic and logopenic variants of primary progressive aphasia.
    Croot K; Ballard K; Leyton CE; Hodges JR
    J Speech Lang Hear Res; 2012 Oct; 55(5):S1562-72. PubMed ID: 23033449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Progressive Aphasia Associated With
    Saracino D; Ferrieux S; Noguès-Lassiaille M; Houot M; Funkiewiez A; Sellami L; Deramecourt V; Pasquier F; Couratier P; Pariente J; Géraudie A; Epelbaum S; Wallon D; Hannequin D; Martinaud O; Clot F; Camuzat A; Bottani S; Rinaldi D; Auriacombe S; Sarazin M; Didic M; Boutoleau-Bretonnière C; Thauvin-Robinet C; Lagarde J; Roué-Jagot C; Sellal F; Gabelle A; Etcharry-Bouyx F; Morin A; Coppola C; Levy R; Dubois B; Brice A; Colliot O; Gorno-Tempini ML; Teichmann M; Migliaccio R; Le Ber I;
    Neurology; 2021 Jul; 97(1):e88-e102. PubMed ID: 33980708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pathology in primary progressive language and speech disorders.
    Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F
    Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.
    Josephs KA; Duffy JR; Fossett TR; Strand EA; Claassen DO; Whitwell JL; Peller PJ
    Arch Neurol; 2010 May; 67(5):596-605. PubMed ID: 20457960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.
    Bergeron D; Gorno-Tempini ML; Rabinovici GD; Santos-Santos MA; Seeley W; Miller BL; Pijnenburg Y; Keulen MA; Groot C; van Berckel BNM; van der Flier WM; Scheltens P; Rohrer JD; Warren JD; Schott JM; Fox NC; Sanchez-Valle R; Grau-Rivera O; Gelpi E; Seelaar H; Papma JM; van Swieten JC; Hodges JR; Leyton CE; Piguet O; Rogalski EJ; Mesulam MM; Koric L; Kristensen N; Pariente J; Dickerson B; Mackenzie IR; Hsiung GR; Belliard S; Irwin DJ; Wolk DA; Grossman M; Jones M; Harris J; Mann D; Snowden JS; Chrem-Mendez P; Calandri IL; Amengual AA; Miguet-Alfonsi C; Magnin E; Magnani G; Santangelo R; Deramecourt V; Pasquier F; Mattsson N; Nilsson C; Hansson O; Keith J; Masellis M; Black SE; Matías-Guiu JA; Cabrera-Martin MN; Paquet C; Dumurgier J; Teichmann M; Sarazin M; Bottlaender M; Dubois B; Rowe CC; Villemagne VL; Vandenberghe R; Granadillo E; Teng E; Mendez M; Meyer PT; Frings L; Lleó A; Blesa R; Fortea J; Seo SW; Diehl-Schmid J; Grimmer T; Frederiksen KS; Sánchez-Juan P; Chételat G; Jansen W; Bouchard RW; Laforce RJ; Visser PJ; Ossenkoppele R
    Ann Neurol; 2018 Nov; 84(5):729-740. PubMed ID: 30255971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.